Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
896 studies found for:    "Embolism and Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Embolism and Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Completed Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Conditions: Blood Disease;   Anemia, Sickle Cell;   Cerebrovascular Disorders;   Cerebral Embolism and Thrombosis
Intervention:
3 Completed Stroke Prevention in Sickle Cell Anemia (STOP 1)
Conditions: Anemia, Sickle Cell;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Hematologic Diseases;   Hemoglobinopathies
Intervention: Procedure: blood transfusion
4 Completed Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Conditions: Arrhythmia;   Atrial Fibrillation;   Cardiovascular Diseases;   Cerebral Embolism and Thrombosis;   Cerebrovascular Disorders;   Heart Diseases;   Thrombophlebitis;   Cerebrovascular Accident
Intervention: Drug: warfarin
5 Completed The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
Condition: Embolism and Thrombosis
Interventions: Drug: Dalteparin;   Drug: Warfarin
6 Completed The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Conditions: Embolism and Thrombosis;   Embolism;   Vascular Diseases;   Warfarin;   Venous Thromboembolism;   Thrombosis;   Thromboembolism
Intervention: Other: CYP 2C9 and VKORC1 Testing for Warfarin
7 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176b 15mg;   Drug: DU-176b 30mg;   Drug: Enoxaparin sodium 20 mg (=2000IU)
8 Completed Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
Conditions: Venous Thromboembolism;   Embolism and Thrombosis;   Hip Fractures
Intervention: Drug: TTP889
9 Completed
Has Results
Epidemiology of Thromboembolism Disease: A Cohort Study
Conditions: Vascular Diseases;   Embolism and Thrombosis;   Phlebitis;   Venous Insufficiency;   Pulmonary Embolism
Intervention: Other: procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis
10 Completed
Has Results
Registry of AngioJet Use in the Peripheral Vascular System
Conditions: Peripheral Vascular Disease;   Embolism and Thrombosis;   Venous Thrombosis
Intervention:
11 Enrolling by invitation Comparison of Accidents and Their Circumstances With Oral Anticoagulants
Conditions: Cardiovascular Complications;   Hemorrhagic Disorders;   Embolism and Thrombosis
Intervention: Other: Follow up
12 Not yet recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
13 Recruiting A Complex Contraception Registry
Conditions: Diabetes;   Cardiovascular Disease;   Epilepsy;   Migraine;   Neurological Disorders;   Cancer;   Bariatric Surgery Candidate;   Organ or Tissue Transplant; Complications;   Lupus Erythematosus, Systemic;   Other Hematologic Conditions;   Other Venous Embolism and Thrombosis
Intervention:
14 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
15 Completed
Has Results
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Condition: Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
16 Recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
17 Completed A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
Condition: Thromboembolism
Interventions: Drug: Certoparin;   Drug: Unfractionated Heparin
18 Active, not recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
19 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
20 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years